ISSN 2097-6054(网络) ISSN 1672-9234(印刷) CN 11-5289/R
主管:中国科学技术协会 主办:中华护理学会
出版:中华护理杂志社
收录:中国科学引文数据库(CSCD)来源期刊
   中国期刊全文数据库
   中国核心期刊(遴选)数据库
   Scopus

中华护理教育 ›› 2019, Vol. 16 ›› Issue (7): 541-543.doi: 10.3761/j.issn.1672-9234.2019.07.016

• 临床实践 • 上一篇    下一篇

甲状腺癌患者行 131I治疗后体外辐射剂量变化研究

陈伟娜,韩星敏,周纪妹,贺旖君   

  1. 450000 郑州市 郑州大学第一附属医院
  • 收稿日期:2018-09-04 出版日期:2019-07-20 发布日期:2019-08-08
  • 作者简介:陈伟娜:女,本科,主管护师,E-mail: 2873147431@qq.com

Radiation dose changes of thyroid cancer patients after 131I treatment

Wei-na CHEN,Xing-min HAN,Ji-mei ZHOU,Yi-jun HE   

  • Received:2018-09-04 Online:2019-07-20 Published:2019-08-08

摘要: 目的 了解分化型甲状腺癌术后行 131I治疗的患者体外辐射剂量变化,探讨患者出院日及临床过程中的辐射防护方法。 方法 选取分化型甲状腺癌术后进行 131I治疗的患者74例,在治疗后24 h、48 h、72 h、96 h,使用放射性核素治疗监护机器人测量距患者颈部及1 m处的体外辐射剂量水平,并与出院参考标准进行比较。 结果131I治疗后24 h、48 h、72 h、96 h,距患者1 m处辐射剂量为270.11(202.46,427.18)、64.02(39.01,101.19)、16.74(10.07,27.69)、5.28(3.41,10.40);行 131I治疗后24 h、48 h、72 h、96 h,辐射剂量符合出院要求的患者分别为0例、2例(2.7%)、52例(70.3%)、70例(94.6%)。 结论 甲状腺癌患者行 131I治疗后体外辐射剂量变化差异性较大,建议动态检测患者行 131I治疗后1 m处的体外辐射剂量,按照辐射剂量要求执行个体化出院时间。医护人员接触患者时要做好防护,可使用放射性核素治疗监护机器人完成部分工作。

关键词: 甲状腺肿瘤, 碘放射性同位素, 病人隔离, 辐射监测

Abstract: Objective To understand the radiation dose changes of patients receiving iodine after operation for differentiated thyroid cancer,and to discuss the best protection when patients were discharged and during the process of staying in hospital.Methods A total of 74 patients with differentiated thyroid cancer who received 131I treatment after surgery were selected. At 24 h,48 h,72 h and 96 h after treatment,the radiation dose levels on the neck and 1m far away from the patients were measured by the radionuclide therapy monitoring robot,and compared with the reference standards of discharge. Results At 24 h,48 h,72 h and 96 h after 131I treatment,the radiation dose 1m away from the patient was 270.11(202.46,427.18),64.02(39.01,101.19),16.74(10.07,27.69),5.28(3.41,10.40)respectively. At 24 h,48 h,72 h and 96 h after 131I treatment,0 patient,2 patients(2.7%),52 patients(70.3%)and 70 patients(94.6%)met the discharge dose requirements. Conclusion Radiation dose changes of thyroid cancer patients after 131I treatment is great among different patients. It is suggested to dynamically detect the radiation dose at 1 m after 131I treatment and individualized discharge schedule is advocated. Medical staff should be well protected when contacting patients,and the radionuclide therapy monitoring robot can be used to complete part of the work.

Key words: Thyroid Neoplasms, Iodine Radioisotopes, Patient Isolation, Radiation Monitorin